← Open Payments lookup

MICHAL TOMASZEWICZ: Open Payments

NPI 1326496514 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$566 in 22 payments from 8 companies in 2025. Trend: 2023 $601 · 2024 $502 · 2025 $566

Food & beverage: $566
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$148
E.R. Squibb & Sons, L.L.C.3$105
Axsome Therapeutics, Inc.4$97
Neurocrine BioSciences, Inc.3$77
Alkermes, Inc.3$58
Vanda Pharmaceuticals Inc.1$34
Otsuka America Pharmaceutical, Inc.2$33
Teva Pharmaceuticals USA, Inc.1$14

Products named: CAPLYTA, COBENFY, Auvelity, INGREZZA, LYBALVI, FANAPT, REXULTI, AUSTEDO XR.

Industry payments across DE — which companies pay providers there.